Novel hydro- and lipo-philic selenium zinc(II) phthalocyanines: Synthesis, photophysical properties and photodynamic effects on CT26 colon carcinoma cells
Source abstract
Abstract
Abstract The synthesis and photochemical properties of two novel selenium zinc(II) phthalocyanines, a lipid-soluble 2,9(10),16(17),23(24)-tetrakis [(2-dimethylamino)ethylselanyl]phthalocyaninato zinc(II) (4) and its water-soluble quaternized derivative 2,9(10),16(17),23(24)-tetrakis [(2- trimethylammonium)ethylselanyl]phthalocyaninato zinc(II) tetraiodide (5), were investigated. Maximum absorption values were 689 nm and 684 nm for 4 and 5 in DMF, respectively. In addition, phthalocyanines were revealed to be very efficient singlet oxygen generators with high values of ΦΔ 0.74 and 0.84 for 4 and 5 in DMF, and they were photostable over the irradiation times studied. The photodynamic effect were evaluated on CT26 colon carcinoma cells. After light exposure, 4 and 5 were found to be cytotoxic, and IC50 values were 0.5 ± 0.1 μM and 2.3 ± 0.6 μM, respectively. The production of a greater amount of reactive oxygen species after phthalocyanines irradiation would be responsible for its potent phototoxic action on CT26 colon carcinoma cells.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Photodynamic therapy10.1093/jnci/90.12.889 ↗
2. Current clinical and preclinical photosensitizers for use in photodynamic therapy10.1021/jm040074b ↗
3. Photodynamic therapy for the treatment of non-small cell lung cancer
4. Photodynamic therapy of bladder cancer. A new option10.1007/s00120-013-3306-2 ↗
5. Photodynamic therapy with a novel porphyrin-based photosensitizer against human gastric cancer10.3892/ol.2015.3953 ↗
6. Photodynamic therapy in gynaecologic cancer10.1016/S1011-1344(96)07370-8 ↗
7. Photodynamic therapy for non-melanoma skin cancers10.3390/cancers8100090 ↗
8. Metal complexes as photo- and radiosensitizers10.1021/cr980439y ↗
9. Basic Principles of photodynamic therapy10.1002/jpp.328 ↗
10. Current clinical and preclinical photosensitizers for use in photodynamic therapy10.1021/jm040074b ↗
11. Synthesis and characterization of novel zinc phthalocyanines as potential photosensitizers for photodynamic therapy of cancers10.1039/C3PP50393C ↗
12. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy10.1039/cs9952400019 ↗
13. Synthesis, photophysical and photochemical aspects of phthalocyanines for photodynamic therapy10.2174/1385272033373076 ↗
14. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy10.1016/S1011-1344(96)07352-6 ↗
15. Water-soluble quaternized mercaptopyridine-substituted and bovine serum albumin binding properties10.1016/j.dyepig.2011.02.007 ↗
16. Bioisosterism: a useful strategy for molecular modification and drug design10.2174/0929867053363540 ↗
17. Photodynamic effects of isosteric water-soluble phthalocyanines on human nasopharynx KB carcinoma cells10.1016/j.ejmech.2010.06.002 ↗
18. Phototoxic action of a zinc(II) phthalocyanine encapsulated into poloxamine polymeric micelles in 2D and 3D colon carcinoma cell cultures10.1016/j.jphotobiol.2017.04.009 ↗
19. Photodynamic effects of zinc(II) phthalocyanine-loaded polymeric micelles in human nasopharynx KB carcinoma cells10.1111/j.1751-1097.2012.01229.x ↗
20. Synthesis and properties of a novel alkylselenium substituted phthalocyanine10.1016/j.tetlet.2015.05.027 ↗
21. Desiccant efficiency in solvent drying. Dipolar aprotic solvents10.1021/jo00414a038 ↗
22. β-dimethylaminoethyl chloride hidrochloride [Ethylamine, 2-chloro-N,N-dimethyl-, hydrochloride]
23. Visible and near IR spectroscopical and photochemical characterization of substituted metallophthalocyanines10.1016/1010-6030(93)85022-Z ↗
24. Photophysical properties of supported dyes. Quantum yield calculations in scattering media10.3184/007967401103165235 ↗
25. Photo-oxidative stability and its correlation with semi-empirical MO calculations of various tetraazaporphyrin derivatives in solution10.1002/(SICI)1099-1409(199704)1:2<159::AID-JPP19>3.0.CO;2-8 ↗
26. Stillman · 1989 · vol. 1
27. Reduction of an amido zinc(II) phthalocyanine by diborane
28. Solvent effects on the photochemical and fluorescence properties of zinc phthalocyanine derivatives10.1016/S0022-2860(03)00155-8 ↗
29. Oxidative photobleaching of phthalocyanines in solution10.1142/S1088424612300042 ↗
30. In vivo transport and pharmacokinetic behavior of tumour photosensitizers
31. Interaction of hydro- or lipophilic phthalocyanines with cells of different metastatic potential10.1016/S0006-2952(95)02174-4 ↗
32. Photodynamic therapy against achromic M6 melanocytes: phototoxicity of lipophilic axially substituted aluminum phthalocyanines and hexadecahalogenated zinc phthalocyanines10.1002/jpp.343 ↗
33. Synthesis and comparative photodynamic properties of two isosteric alkyl substituted zinc(II) phthalocyanines10.1016/j.ejmech.2011.09.014 ↗
34. Photophysics and photobiology of novel liposomal formulations of 2,9(10),16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II)10.1016/j.dyepig.2012.11.005 ↗
35. Photodynamic therapeutics: basic principles and clinical applications10.1016/S1359-6446(99)01412-9 ↗
36. Photodynamic therapy of cancer: an update10.3322/caac.20114 ↗